Gingival enlargement in a pregnant woman with acute monocytic leukaemia: a case report

Leukemia

Complete molecular remission in relapsed and refractory acute myeloid leukaemia with MLL-AF9 treated with chidamide-based chemotherapy

J Clin Pharm Ther.

Lun Y, Yang JJ, Wu Y

doi: 10.1111/jcpt.12577.

Myeloproliferative Neoplasms (MPNs)

Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia

JAMA Oncol.

Ertz-Archambault N, Kosiorek H, Taylor GE, Kelemen K, Dueck A, Castro J, Marino R, Gauthier S, Finn L, Sproat LZ, Palmer J, Mesa RA, Al-Kali A, Foran J, Tibes R

doi: 10.1001/

Leukemia

Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia

Br J Cancer.

Forero-Castro M, Robledo C, Benito R, Bodega-Mayor I, Rapado I, Hernández-Sánchez M, Abáigar M, Maria Hernández-Sánchez J, Quijada-Álamo M, María Sánchez-Pina J, Sala-Valdés M, Araujo-Silva F, Kohlmann A, Luis Fuster J, Arefi M, de Las Heras N, Riesco S, Rodríguez JN, Hermosín L, Ribera J, Camos Guijosa M, Ramírez M, de Heredia Rubio CD, Barragán E, Martínez J, Ribera JM, Fernández-Ruiz E, Hernández-Rivas JM

doi: 10.1038/bjc.2017.152.

Leukemia

A successful multidisciplinary approach for treatment and for preserving the reproductive potential in a rare case of acute lymphocytic leukemia during pregnancy

Gynecol Endocrinol.

Salama M, Isachenko E, Ludwig S, Einzmann T, Rahimi G, Mallmann P, Isachenko V

doi: 10.1080/09513590.

Leukemia

Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia

Antioxidants (Basel).

Foster MN, Carr AC, Antony A, Peng S, Fitzpatrick MG

doi: 10.3390/antiox7070092.

Leukemia

Acute promyelocytic leukaemia lying under the mask of COVID-19-a diagnostic and therapeutic conundrum

Br J Haematol.

Farmer I, Okikiolu J, Steel M, Wanniarachchi C, Littlewood S, Gupta S, Thanigaikumar M, Oram SH, Moonim M, Kulasekararaj AG, Yeghen T

doi: 10.1111/bjh.16864.

Leukemia

Acute central nervous system complications and ammonium levels in adult patients with acute lymphoblastic leukemia receiving l-asparaginase

Leuk Lymphoma.

Strickler N, Balabanov S, Casauro K, Schanz U, Manz MG, Gerber B

doi: 10.1080/

Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial

Lancet Oncol.

Locatelli F, Bernardo ME, Bertaina A, Rognoni C, Comoli P, Rovelli A, Pession A, Fagioli F, Favre C, Lanino E, Giorgiani G, Merli P, Pagliara D, Prete A, Zecca M

doi: 10.1016/

Leukemia

COVID-19 in a patient with pre-existing acute lymphoblastic leukemia

Br J Haematol.

Wu Y, Lin H, Xie Q, Chen Q, Huang Y, Zhu Y, Chen L

doi: 10.1111/bjh.16799.

Related content

Complete molecular remission in relapsed and refractory acute myeloid leukaemia with MLL-AF9 treated with chidamide-based chemotherapy

Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia

Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia

A successful multidisciplinary approach for treatment and for preserving the reproductive potential in a rare case of acute lymphocytic leukemia during pregnancy

Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia

Acute promyelocytic leukaemia lying under the mask of COVID-19-a diagnostic and therapeutic conundrum

Acute central nervous system complications and ammonium levels in adult patients with acute lymphoblastic leukemia receiving l-asparaginase

Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial

COVID-19 in a patient with pre-existing acute lymphoblastic leukemia